Health · 37 views
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine on Thursday, the first made with the same mRNA technology that was key to ending the Covid-19…
Summary
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine on Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- ESMO: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancerContinue reading
- Scientists propose national microbiome plan to prevent chronic diseaseContinue reading
- I'm a Forensic Psychiatrist. Here's My Take on the Elizabeth Holmes Documentary.Continue reading
- mRNA Melanoma Vaccine Cuts Risk of Recurrence or Death, Leaked Trial Data ShowContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow